undamentalytics Newsletter

Steris dividend history

Steris's dividend was $2.46 a share in fiscal 2026, up 10.3% on the year before. That was 30.9% of net income. It has raised its dividend per share every year since fiscal 2017, as far back as our figures go.

Dividends, buybacks and capital spending

FY2027 Q1 TTM
Buybacks (TTM)
$340M
Dividends (TTM)
$247M
Returned to shareholders
63%
of free cash flow
Buybacks, last 3 fiscal years
$459M
Diluted share count
−0.5%
year over year
Total shareholder yield
2.6%
dividends 1.1% + buybacks 1.5% of market value
Dividend payout ratio
31%
of net income paid out
R&D spending
1.9%
of revenue
Sales & admin spending
23.6%
of revenue
Days sales outstanding
61 days
receivables vs revenue

Dividends by fiscal year

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Steris: dividends by fiscal year, annual
Fiscal year2017Mar 20172018Mar 20182019Mar 20192020Mar 20202021Mar 20212022Mar 20222023Mar 20232024Mar 20242025Mar 20252026Mar 2026LTMJun 2026
Dividend per share$1.09$1.21$1.33$1.45$1.57$1.69$1.84$2.03$2.23$2.46—
Dividend per share growth—+11.0%+9.9%+9.0%+8.3%+7.6%+8.9%+10.3%+9.9%+10.3%—
Dividends paid93103113123134163183201220242247
Share buybacks98658151155630912211236340
Dividends ÷ net income84.7%35.4%37.0%30.2%33.7%66.9%171.4%53.0%35.8%30.9%30.7%
Dividends ÷ free cash flow37.1%35.2%32.2%32.7%29.7%41.1%46.5%32.7%28.3%24.9%26.7%

Dividend per share is the amount declared for the fiscal year as stated in the company's filings (including any special dividend), restated for stock splits and checked against the cash dividends paid. Dividends paid and buybacks are cash amounts; the last-twelve-months column can include an extra payment when a quarter-end date moves.

Compare with peers

Head to head: RMD vs STE

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Steris's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Steris.